𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease

✍ Scribed by Eng-King Tan; Yanni Tan; Anthea Chai; Christopher Tan; Hui Shen; Sau-Ying Lum; Stephanie M.C. Fook-Cheong; Mei-Ling Teoh; Yuan Yih; Meng-Cheong Wong; Yi Zhao

Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
248 KB
Volume
18
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

In a case control study, we examined the association of DRD2 Taq1A and Taq1B polymorphisms and risk of PD, and evaluated the strength of linkage disequilibrium of the polymorphisms. The Taq1A and Taq1B polymorphisms were in strong linkage disequilibrium. There was, however, no significant association of the two polymorphisms with PD. Β© 2003 Movement Disorder Society

πŸ“œ SIMILAR VOLUMES

Dopamine D2 receptor TaqI A polymorphism
Dopamine D2 receptor TaqI A polymorphism and Parkinson's disease
✍ Mario Zappia; Grazia Annesi; Aldo Quattrone πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 9 KB

We read with interest the article by Grevle and colleagues, 1 reporting in Norway an association between the variant allele A1 of the TaqI A restriction fragment length polymorphism (RFLP) located in the dopamine D2 receptor (DRD2) gene and Parkinson's disease (PD). Similar findings have been report

The DRD2 TaqIA polymorphism and demand o
The DRD2 TaqIA polymorphism and demand of dopaminergic medication in Parkinson's disease
✍ Sebastian Paus; Anne GrΓΌnewald; Christine Klein; Michael Knapp; Alexander Zimpri πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 64 KB πŸ‘ 1 views

## Abstract Previous studies have demonstrated that the __TaqIA__ polymorphism of the D2 dopamine receptor gene (__DRD__2) is associated with response to dopaminergic and antidopaminergic treatment in Parkinson's disease (PD) and schizophrenia, respectively. We tested whether the __TaqIA__ genotype

Dopamine receptor gene polymorphisms in
Dopamine receptor gene polymorphisms in Parkinson's disease patients reporting β€œsleep attacks”
✍ Ida Rissling; Frank Geller; Oliver Bandmann; Karim Stiasny-Kolster; Yvonne KΓΆrne πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 70 KB πŸ‘ 1 views

## Abstract Genes encoding proteins involved in dopaminergic transmission are potential candidate genes for the induction of somnolence in Parkinson's disease (PD) because dopaminergic agents have been shown to be associated with sudden onset of sleep (SOS) in PD. We conducted an association study

Insular dopamine D2 receptors and novelt
Insular dopamine D2 receptors and novelty seeking personality in Parkinson's disease
✍ Valtteri Kaasinen; Sargo Aalto; Kjell NΓ₯gren; Juha O. Rinne πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 90 KB πŸ‘ 1 views

## Abstract Novelty seeking is a temperament trait characterized by impulsiveness and exploratory behavior. Dopamine has been suggested to be the primary neurotransmitter modulator of novelty seeking, and in young healthy subjects, a correlation between increased novelty seeking and decreased insul

Association study of dopamine D2, D3, D4
Association study of dopamine D2, D3, D4 receptor and serotonin transporter gene polymorphisms with sleep attacks in Parkinson's disease
✍ Sebastian Paus; Gert Seeger; Hans M. Brecht; JΓΌrgen KΓΆster; Mahha El-Faddagh; Ma πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 47 KB πŸ‘ 1 views

Sleep attacks are a common yet only recently recognized phenomenon in patients with Parkinson's disease (PD). Initially reported to occur only with particular dopamine agonists, sleep attacks have been observed with all dopaminergic drugs. [1][2][3] In the majority of affected patients, sleep attack